Table 3.
Neutralizing capability of selected bovine serum samples from calves on the infectivity of a genotype 3 human HEV (Kernow P6 strain) in HepG2/C3A human liver cells
| Bovine Serum ID and controls | Date of sample collection | ELISA O.D. value | Individual S/C.O. value | % Decrease in HEV infectivitya | Sample neutralizing antibody titer |
|---|---|---|---|---|---|
| PBS | N/A | N/A | N/A | 0 | N/A |
| Chimp 1313 | N/A | N/A | N/A | 91.87 | N/A |
| 5078 | 1/14/13 | 0.411 | 2.658 | 48.56 | 1:16 |
| 5082 | 12/5/12 | 0.340 | 2.270 | 46.9 | 1:4 |
| 5082 | 1/10/13 | 3.125 | 20.851 | 49.28 | 1:16 |
All bovine sera were tested in dilutions 1:10, 1:100 and 1:1000, and were also titered in serial dilutions from 1:2 to 1:8192 in a serum virus neutralization assay. Chimp 1313 is a hyperimmune HEV antisera as a positive control with at least 105 IgG ELISA titer against HEV from a chimpanzee experimentally-infected with HEV.